Royalty Pharma Ownership | Who Owns Royalty Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

Royalty Pharma Ownership Summary


Royalty Pharma is owned by 85.45% institutional investors, 6.49% insiders, and 8.06% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.94% of RPRX shares. American Funds New Perspective A is the top mutual fund, with 4.43% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRoyalty Pharma85.45%6.49%8.06%
SectorHealthcare Stocks 50.47%12.28%37.25%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley42.93M9.94%$2.41B
Capital investors35.27M8.17%$1.98B
Blackrock funding, inc. /de27.83M6.44%$1.56B
Fmr24.51M5.68%$1.37B
Blackrock23.02M5.13%$606.97M
State street12.34M2.86%$691.80M
Price t rowe associates inc /md/11.19M2.59%$627.63M
Swedbank ab10.73M2.48%$601.44M
Baillie gifford10.02M2.32%$561.57M
Vanguard group9.93M2.30%$383.87M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caledonia (private) investments pty5.78M11.06%$323.85M
Davern capital partners, lp1.16M11.05%$64.81M
Dorsey asset management2.46M8.82%$137.74M
Regal partners2.45M7.58%$137.25M
Patient capital management3.60M6.61%$201.79M
New south capital management2.39M5.87%$133.78M
Lion point capital, lp21.40K5.74%$1.20M
Cutter capital management, lp356.89K4.84%$11.11M
Torray investment partners602.03K4.55%$33.76M
Cm management125.00K4.45%$7.01M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/11.19M0.06%9.26M
Norges bank5.34M0.03%5.34M
Sixth street partners management company3.08M0.02%3.08M
Blackrock funding, inc. /de27.83M0.02%1.93M
Blackrock23.02M0.01%1.81M

Top Sellers

HolderShares% AssetsChange
Baillie gifford10.02M0.51%-6.14M
Unisphere establishment---5.00M
Adage capital partners gp2.50M0.20%-4.98M
Ubs asset management americas3.45K--3.09M
Viking global investors lp---2.60M

New Positions

HolderShares% AssetsChangeValue
Norges bank5.34M0.03%5.34M$299.19M
Sixth street partners management company3.08M0.02%3.08M$172.89M
Weiss asset management lp457.47K0.20%457.47K$16.14M
Barrow hanley mewhinney & strauss267.55K0.05%267.55K$15.00M
Panagora asset management240.18K0.04%240.18K$13.47M

Sold Out

HolderChange
Grove bank & trust-1.00
Wealth watch advisors-1.00
Financial gravity asset management-2.00
Toth financial advisory-3.00
Harbor investment advisory-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20266508.51%369,051,8523.15%851.25%39916.67%175-3.31%
Mar 31, 2026454-16.08%200,591,255-43.79%460.67%256-24.26%137-
Dec 31, 2025409-17.71%269,689,122-17.74%621.09%253-14.53%102-24.44%
Sep 30, 20254823.43%326,746,376-4.38%751.16%28715.26%130-16.13%
Jun 30, 2025456-1.30%341,289,0057.83%801.51%248-1482.07%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds New Perspective A19.65M4.43%-
Capital Group New Perspective Comp19.65M4.43%-
Vanguard US Total Market Shares ETF12.01M2.77%-167.60K
Vanguard Total Stock Mkt Idx Inv11.25M2.60%-258.49K
American Funds Capital Income Bldr A8.58M2.00%6.87M
American Funds Capital Inc Bldr A8.58M1.94%-
American Funds American Balanced A8.02M1.87%-
Vanguard Mid Cap Index Institutional7.99M1.85%86.30K
Capital Group Growth Fnd of Amer Comp7.58M1.71%1.16M
American Funds Growth Fd of Amer A7.58M1.71%1.16M

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2026Coyne Terrance P. EVP & CFOSell$104.80K
Aug 13, 2026Coyne Terrance P. EVP & CFOSell$540.75K
Jul 01, 2026Urist Marshall EVP, Research & InvestmentsSell$508.45K
Jun 24, 2026Urist Marshall EVP, Research & InvestmentsSell$502.07K
Jun 23, 2026Hite Christopher EVP & Chairman, PartneringSell$1.75M

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-11
2026 Q1-23
2025 Q4-28
2025 Q3-1

RPRX Ownership FAQ


Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (42.93M shares, 9.94%), Capital investors (35.27M shares, 8.17%), and Blackrock funding, inc. /de (27.83M shares, 6.44%). Together, they hold 24.55% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Caledonia (private) investments pty is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 11.06% of its assets in 5.78M Royalty Pharma shares, valued at 323.85M$.

Who is the top mutual fund holder of Royalty Pharma shares?

American Funds New Perspective A is the top mutual fund holder of Royalty Pharma shares, with 4.43% of its total shares outstanding invested in 19.65M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools